CD8A and neoplasm: Since that the TIGIT/PVR immune checkpoint axis plays a major role in the functional regulation of T cells and NK cells, we also explored the role of CD4+, CD8+ T and NK cells in the tumor inhibition mediated by liothyronine therapy.